Luca Vincenzo Cappelli

13PUBLICATIONS
71CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyEconometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 12, 2026
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack® Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL Study.

|Mar 12, 2026
Very long-term outcomes of chronic-phase chronic myeloid leukaemia patients treated with imatinib: A 25-year real-world cohort study.

Alessandro Costa, Emilia Scalzulli, Ida Carmosino

|Feb 21, 2026
Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.

Silvio Ligia, Giovanni Manfredi Assanto, Tania Soriano

|Jul 02, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma.

Claudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli

|Jun 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.

Alyssa Bouska, Weiwei Zhang, Sunandini Sharma

|Feb 16, 2023
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.

Ilaria Del Giudice, Luca Vincenzo Cappelli, Julio Delgado

Pageof 3

Frequent Collaborators

4 joint publications

Irene Della Starza

4 joint publications

Ilaria Del Giudice

4 joint publications

Giorgio Inghirami

4 joint publications

Danilo Fiore